Card image cap
Azithromycin helps reducing hospitalisation in AECOPD cases

Azithromycin usage resulted in less treatment failure in AECOPD which was driven by lower readmission rates and prescription of new antimicrobials, suggests a recent research carried out by a team of scientists at Department of Pharmacy, Ascension St. John Hospital, Detroit. The research findings, published in PubMed, also observed how beta-lactams continued to demonstrate a higher risk for treatment failure. The researchers wrote that they analysed 595 patients, of which 428 (72%) received azithromycin and 167 patients (28%) received a beta-lactam to find that the composite primary outcome, which was treatment failure in rate in patients, occurred in 84 patients (19.6%) in the azithromycin group and 54 (32.3%) in the beta-lactam group.

Elevate your practice with our advanced AI-based CDSS Tool.Transform your practice now!

Disclaimer :
The author(s)' thoughts and opinions in this article are their own and do not necessarily reflect DocMode's viewpoint. The article is in no way created or edited by DocMode.

Submit a Comment